Amgen was aiming to launch its cholesterol-fighter Repatha quickly in India. But a panel of CV and renal specialists blocked the PCSK9 drug instead.

Despite a renewed push by health officials to promote HPV vaccination, a new poll finds that only a minority of parents believe laws requiring the vaccines “…

This year’s stock market hasn’t been easy for pharma. Unwelcome news has sent some drugmakers' shares tumbling--as much as 72%, in one notorious case.

Valeant CEO Joseph Papa has filled another link in the company's executive rank, hiring Zoetis and Warner Chilcott veteran Paul S. Herendeen, as chief…

Boehringer's Pradaxa won an edge on its new-age anticoagulant rivals last year when the FDA approved a reversal agent. It'll hang onto that edge, at…

Here's an unintended consequence of high drug prices: Patients feel entitled to pharma's help in paying for them.

Chinese development venture will boost biotech R&D space in South San Francisco by a fifth, says city manager.

With her poolside reporting assignment at the Olympics in Rio behind her, Olympic swimmer and 12-time medalist Dara Torres is turning her attention to another…